Vaginal Mesh Complications Prompt New Bill to Amend FDA Device Approval Loophole

Share Article

Bernstein Liebhard LLP reports on a new bill that seeks to amend an FDA loophole, which allows for market approval of surgical mesh and other medical devices. Lawmakers cite vaginal mesh complications and other dangerous side effects associated with these devices for support.

Bernstein Liebhard LLP reports on new legislation proposed by Representative Edward Markey (D-MA) which will alleviate concerns and reform the 510(k) loophole in the U.S. Food and Drug Administration’s (“FDA”) approval process for medical devices.* Currently, medical device manufacturers can utilize the 510(k) process to receive market approval for devices such as surgical mesh without having to undergo rigorous clinical testing by claiming that the devices are substantially similar to prior versions, even if the prior versions have been recalled.** The new bill, Safety of Untested and New Devices (“SOUND”) Act, would give the FDA authority to request documentation from manufactures to demonstrate that a new product’s design has addressed and fixed potential problems if it is based on a prior version with safety issues. During a press conference on March 22, 2012, Representative Markey cited vaginal mesh complications stemming from transvaginal surgical mesh devices, which were approved under the current system, to support his calls for reform. According to the Boston Globe, Markey said in an interview following the briefing that he hoped the legislation would be added to a larger bill about medical devices that Congress is set to vote on at the end of May. “[The] loophole in our current law actually requires the FDA to approve certain kinds of medical devices even if they have reason to believe [the devices] may harm or even kill patients,” Markey said.

In light of this latest development, Bernstein Liebhard LLP partner Jeffrey S. Grand, who is serving as co-liaison counsel in the New Jersey transvaginal surgical mesh lawsuits against Johnson & Johnson and C.R. Bard, another medical device manufacturer, commented “The problems with transvaginal mesh have become a serious public health issue and are indicative that the FDA approval process needs reform. While we believe further reform is needed, this bill is a step in the right direction.”

Vaginal Mesh Complications and Mounting Litigation Supports Need For New Legislation

According to the Boston Globe, an FDA spokesperson, Karen Riley, while not officially endorsing the bill, said that the agency has raised the issue of the loophole of the 510(k) process to members of Congress and believes that the new legislation would “provide appropriate protections for public health.” As Riley told the Boston Globe, “a new device is five times as likely to be recalled with a design flaw if it is based on an older device that was itself pulled for safety problems.”

Markey appeared at the briefing for the bill with Jay Nevarez, a woman from Colorado who experienced transvaginal mesh complications after receiving a vaginal mesh implant that was based on a previously recalled device. Nevarez is just one of many individuals involved in pelvic mesh litigation litigation against Johnson & Johnson/Ethicon. The Gynecare TVT vaginal mesh implant Nevarez received was approved by the FDA based on its similar design to Boston Scientific’s ProtoGen, which was recalled nearly a decade earlier due to the post-surgical complications it caused. As a result of the vaginal mesh complications, Nevarez told the Boston Globe, “I lost my job and my health, and am in the process of losing my home.”

The lawyers at Bernstein Liebhard are actively filing cases in In re Pelvic Mesh/Gynecare Litigation, No. 6341-10 (N.J. Super Ct.), and In re Pelvic Mesh Litigation/Bard No. L-6339-10 (N.J. Super. Ct.), which are two consolidated actions of all the vaginal surgical mesh lawsuits filed in New Jersey state court.        

Those who have experienced transvaginal mesh complications may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries. For more information about filing a vaginal mesh lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at info(at)consumerinjurylawyers(dot)com. Our lawyers and staff understand the sensitive nature of the complications caused by transvaginal mesh and will answer your questions in a caring and sympathetic manner.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website